Cellular and molecular mechanisms of metformin: an overview
Open accessThe DOI matches its Crossref record; 167 of the 167 references it cites were found in a registry or an index.
Abstract
Considerable efforts have been made since the 1950s to better understand the cellular and molecular mechanisms of action of metformin, a potent antihyperglycaemic agent now recommended as the first-line oral therapy for T2D (Type 2 diabetes). The main effect of this drug from the biguanide family is to acutely decrease hepatic glucose production, mostly through a mild and transient inhibition of the mitochondrial respiratory chain complex I. In addition, the resulting decrease in hepatic energy status activates AMPK (AMP-activated protein kinase), a cellular metabolic sensor, providing a generally accepted mechanism for the action of metformin on hepatic gluconeogenesis. The demonstration that respiratory chain complex I, but not AMPK, is the primary target of metformin was recently strengthened by showing that the metabolic effect of the drug is preserved in liver-specific AMPK-deficient mice. Beyond its effect on glucose metabolism, metformin has been reported to restore ovarian function in PCOS (polycystic ovary syndrome), reduce fatty liver, and to lower microvascular and macrovascular complications associated with T2D. Its use has also recently been suggested as an adjuvant treatment for cancer or gestational diabetes and for the prevention in pre-diabetic populations. These emerging new therapeutic areas for metformin will be reviewed together with recent findings from pharmacogenetic studies linking genetic variations to drug response, a promising new step towards personalized medicine in the treatment of T2D.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In PCOS, metformin reduces insulin resistance and inhibits ovarian androgen production via effects on steroidogenic acute regulatory protein and 17alphahydroxylase (Diamanti-Kandarakis et al. , 2010; Viollet et al. , 2012).”
From Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis (2015) · cites this paper as Viollet et al., 2012
The cited source says what the claim attributes to it.
In the citing paper
“a drug that is currently being used to treat type II diabetic patients, metformin [74], can activate AMPK”
From Senescence of T Lymphocytes: Implications for Enhancing Human Immunity (2016) · cites this paper as [74]
The cited source says what the claim attributes to it.
In the citing paper
“Given the evidence that metformin acts through the mitochondrial electron transport chain (ETC) by inhibiting complex I(46, 210–212) (Figure 8)”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [46]
In the citing paper
“By far the most important mechanism is the reduction in hepatic glucose production that is considered mediated by the activation of the global energy sensor in cells, adenosine monophosphate-activated protein kinase (AMPK) (Figure 1).(46)”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [46]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652 · cited 4×
“Thus, AMPK activation by metformin induces the phosphorylation and inactivation of acetyl CoA carboxylase (ACC), an important rate-controlling enzyme for the synthesis of malonylCoA, which is both a critical precursor for the biosynthesis of fatty acids and a potent inhibitor of mitochondrial fatty acid oxidation [17].”
BackgroundInfluentialHyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Nathan, D. M., Buse, J. B., Davidson, M. B., Ferrannini, E., Holman, R. R., Sherwin, R., & Zinman, B. (2009) · Diabetes Care · doi:10.2337/dc08-9025 · Cited by 3,834
Metformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388 · cited 1×
“Furthermore, the authors found a doseresponse relationship between duration of exposure to metformin and cancer incidence [106].”
BackgroundGiovannucci, E., Harlan, D. M., Archer, M. C., Bergenstal, R. M., Gapstur, S. M., Habel, L. A., Pollak, M., Regensteiner, J. G., & Yee, D. (2010) · Diabetes Care · doi:10.2337/dc10-0666 · Cited by 2,366
OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157
The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin
Shaw, R. J., Lamia, K. A., Vasquez, D., Koo, S.-H., Bardeesy, N., DePinho, R. A., Montminy, M., & Cantley, L. C. (2005) · Science · doi:10.1126/science.1120781 · Cited by 1,950 · cited 25×
“Metformin most likely does not directly activate either LKB1 or AMPK as the drug does not influence the phosphorylation of AMPK by LKB1 in cell-free assay [21].”
BackgroundInfluential
Cited by
Items 101–200 of 1,001
When fats commit crimes: fatty acid metabolism, cancer stemness and therapeutic resistance
Kuo, C., & Ann, D. K. (2018) · Cancer Communications · doi:10.1186/s40880-018-0317-9 · Cited by 146
Lee, C. B., Chae, S. U., Jo, S. J., Jerng, U. M., & Bae, S. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073566 · Cited by 163
Diabetes drugs and neurological disorders: new views and therapeutic possibilities
Patrone, C., Eriksson, O., & Lindholm, D. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70125-6 · Cited by 161
Weight management in patients with type 1 diabetes and obesity
Mottalib, A., Kasetty, M., Mar, J. Y., Elseaidy, T., Ashrafzadeh, S., & Hamdy, O. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0918-8 · Cited by 149
Turn up the power - pharmacological activation of mitochondrial biogenesis in mouse models
Komen, J. C., & Thorburn, D. R. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12413 · Cited by 149
“Among these is the drug metformin, which is widely used for the treatment of type 2 diabetes (Viollet et al., 2012).”
BackgroundGriffith, R. J., Alsweiler, J., Moore, A. E., Brown, S., Middleton, P., Shepherd, E., & Crowther, C. A. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012394.pub3 · Cited by 149
Anti-aging pharmacology: Promises and pitfalls
Vaiserman, A. M., Lushchak, O. V., & Koliada, A. K. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.08.004 · Cited by 151
Metformin and other antidiabetic agents in renal failure patients
Lalau, J., Arnouts, P., Sharif, A., & Broe, M. E. D. (2014) · Kidney International · doi:10.1038/ki.2014.19 · Cited by 159
He, Y., Zhou, C., Huang, M., Tang, C., Liu, X., Yue, Y., Diao, Q., Zheng, Z.-B., & Liu, D. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110663 · Cited by 159
Marini, C., Salani, B., Massollo, M., Amaro, A., Esposito, A. I., Maria Orengo, A., Capitanio, S., Emionite, L., Riondato, M., Bottoni, G., et al. (2013) · Cell Cycle · doi:10.4161/cc.26461 · Cited by 146
Estrada‐Arriaga, E. B., Muñoz, J. E. C., Herrera, A. G., Mólgora, C. G. C., Rivera-Huerta, M. L., Camperos, E. R., Palacios, L. M., Gelover-Santiago, S. L., Pérez-Castrejón, S., Vigueros, L. C., et al. (2016) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2016.07.118 · Cited by 154
Hyperglycemic Stress and Carbon Stress in Diabetic Glucotoxicity
Luo, X., Wu, J., Jing, S., & Yan, L. (2016) · Aging and Disease · doi:10.14336/ad.2015.0702 · Cited by 164
The biochemical alterations underlying post-burn hypermetabolism
Auger, C., Samadi, O., & Jeschke, M. G. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.02.019 · Cited by 161
Metformin for ovulation induction (excluding gonadotrophins) in women with polycystic ovary syndrome
Sharpe, A., Morley, L. C., Tang, T., Norman, R. J., & Balen, A. H. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013505 · Cited by 132
Given, J. E., Loane, M., Garne, E., Addor, M.-C., Bakker, M., Bertaut-Nativel, B., Gatt, M., Klungsoyr, K., Lelong, N., Morgan, M., et al. (2018) · BMJ · doi:10.1136/bmj.k2477 · Cited by 130
Chronic metformin treatment improves post‐stroke angiogenesis and recovery after experimental stroke
Venna, V. R., Li, J., Hammond, M. D., Mancini, N. S., & McCullough, L. D. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12556 · Cited by 134
Pharmaceuticals and personal care products: A critical review of the impacts on fish reproduction
Overturf, M. D., Anderson, J. C., Pandelides, Z., Beyger, L., & Holdway, D. A. (2015) · Critical Reviews in Toxicology · doi:10.3109/10408444.2015.1038499 · Cited by 150
Pharmacological Targeting of Mitochondria in Diabetic Kidney Disease
Cleveland, K. H., & Schnellmann, R. G. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000560 · Cited by 142
Takahashi, A., Kimura, F., Yamanaka, A., Takebayashi, A., Kita, N., Takahashi, K., & Murakami, T. (2014) · Cancer Cell International · doi:10.1186/1475-2867-14-53 · Cited by 135
Effects of Antidiabetic Drugs on Gut Microbiota Composition
Montandon, S., & Jornayvaz, F. (2017) · Genes · doi:10.3390/genes8100250 · Cited by 135
“GLP-1 Receptor Agonists GLP-1 RA are modified peptides sharing homology with GLP-1 [65].”
BackgroundInfluentialNephroprotective Effects of Metformin in Diabetic Nephropathy
Ravindran, S., Kuruvilla, V., Wilbur, K., & Munusamy, S. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25598 · Cited by 132
Buler, M., Aatsinki, S., Izzi, V., Uusimaa, J., & Hakkola, A. J. (2014) · The FASEB Journal · doi:10.1096/fj.13-245241 · Cited by 136
A Comprehensive Review of Calcium Electroporation—A Novel Cancer Treatment Modality
Frandsen, S. K., Vissing, M., & Gehl, J. (2020) · Cancers · doi:10.3390/cancers12020290 · Cited by 132
Soto-Acosta, R., Bautista-Carbajal, P., Cervantes-Salazar, M., Angel-Ambrocio, A. H., & del Angel, R. M. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006257 · Cited by 133
Metformin Beyond Diabetes: Pleiotropic Benefits of Metformin in Attenuation of Atherosclerosis
Forouzandeh, F., Salazar, G., Patrushev, N., Xiong, S., Hilenski, L., Fei, B., & Alexander, R. W. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.001202 · Cited by 126
Zhou, Z., Tang, Y., Jin, X., Chen, C., Lu, Y., Liu, L., & Shen, C. (2016) · Journal of Diabetes Research · doi:10.1155/2016/4847812 · Cited by 127
Metformin, cancer and glucose metabolism
Salani, B., Rio, A. D., Marini, C., Sambuceti, G., Cordera, R., & Maggi, D. (2014) · Endocrine-Related Cancer · doi:10.1530/erc-14-0284 · Cited by 127
Chen, S. C., Brooks, R., Houskeeper, J., Bremner, S. K., Dunlop, J., Viollet, B., Logan, P. J., Salt, I. P., Ahmed, S. F., & Yarwood, S. J. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.11.011 · Cited by 127
Self-citationRahn, S., Zimmermann, V., Viol, F., Knaack, H., Stemmer, K., Peters, L., Lenk, L., Ungefroren, H., Saur, D., Schäfer, H., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.12.004 · Cited by 141
Metformin in breast cancer: preclinical and clinical evidence
De, A., & Kuppusamy, G. (2020) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2019.06.003 · Cited by 124
Metformin promotes tau aggregation and exacerbates abnormal behavior in a mouse model of tauopathy
Barini, E., Antico, O., Zhao, Y., Asta, F., Tucci, V., Catelani, T., Marotta, R., Xu, H., & Gasparini, L. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0082-7 · Cited by 126
Molecular Mechanisms of Metformin for Diabetes and Cancer Treatment
Li, M., Li, X., Zhang, H., & Lü, Y. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01039 · Cited by 135
Clinical Application of Antioxidants to Improve Human Oocyte Mitochondrial Function: A Review
Rodríguez-Varela, C., & Labarta, E. (2020) · Antioxidants · doi:10.3390/antiox9121197 · Cited by 130
Impact of Oxygen on Pancreatic Islet Survival
Komatsu, H., KANDEEL, F. R., & Mullen, Y. (2018) · Pancreas · doi:10.1097/mpa.0000000000001050 · Cited by 127
Mechanism and application of metformin in kidney diseases: An update
Song, A., Zhang, C., & Meng, X. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111454 · Cited by 130
Zhou, J., Xu, G., Yan, J., Li, K., Bai, Z., Cheng, W., & Huang, K. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.02.026 · Cited by 126
Caloric restriction: Beneficial effects on brain aging and Alzheimer’s disease
Van Cauwenberghe, C., Vandendriessche, C., Libert, C., & Vandenbroucke, R. E. (2016) · Mammalian Genome · doi:10.1007/s00335-016-9647-6 · Cited by 121
“Metformin is an insulin-sensitizing drug that is used as a first line oral therapy for the treatment of type 2 diabetes (Viollet et al. 2012).”
BackgroundThe Pharmacogenetics of Type 2 Diabetes: A Systematic Review
Maruthur, N. M., Gribble, M. O., Bennett, W. L., Bolen, S., Wilson, L. M., Balakrishnan, P., Sahu, A., Bass, E., Kao, W. H. L., & Clark, J. M. (2014) · Diabetes Care · doi:10.2337/dc13-1276 · Cited by 119
Metformin regulates global DNA methylation via mitochondrial one-carbon metabolism
Cuyàs, E., Fernández-Arroyo, S., Verdura, S., García, R. Á.-F., Stursa, J., Werner, L., Blanco-González, E., Montes-Bayón, M., Joven, J., Viollet, B., et al. (2018) · Oncogene · doi:10.1038/onc.2017.367 · Cited by 121
Self-citationExpired metformin drug as green corrosion inhibitor for simulated oil/gas well acidizing environment
Haruna, K., Saleh, T. A., & Quraishi, M. A. (2020) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2020.113716 · Cited by 121
Disrupting Circadian Rhythm via the PER1–HK2 Axis Reverses Trastuzumab Resistance in Gastric Cancer
Wang, J., Huang, Q., Hu, X., Zhang, S., Jiang, Y., Yao, G., Hu, K., Xu, X., Liang, B., Wu, Q., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-1820 · Cited by 124
Ainuddin, J., Karim, N., Hasan, A. A., & Naqvi, S. A. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.10.001 · Cited by 119
The Relevance of Insulin Action in the Dopaminergic System
Fiory, F., Perruolo, G., Cimmino, I., Cabaro, S., Pignalosa, F. C., Miele, C., Beguinot, F., Formisano, P., & Oriente, F. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00868 · Cited by 111
Jensterle, M., Kravos, N. A., Pfeifer, M., Kocjan, T., & Janez, A. (2015) · Hormones · doi:10.1007/bf03401383 · Cited by 117
AMP-activated protein kinase: A target for old drugs against diabetes and cancer
Russo, G. L., Russo, M., & Ungaro, P. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.05.023 · Cited by 122
Autophagy and its link to type II diabetes mellitus
Yang, J., Lu, C., Kuo, S., Hsu, Y., Tsai, S. C., Chen, S.-Y., Chen, Y., Lin, Y.-J., Huang, Y.-C., Chen, C., et al. (2017) · Biomedicine · doi:10.1051/bmdcn/2017070201 · Cited by 121
Metformin improves hepatic IRS2/PI3K/Akt signaling in insulin-resistant rats of NASH and cirrhosis
Xu, H., Zhou, Y., Liu, Y., Jian, P., Shou, Q., Chen, F., & Ruo, R. (2016) · Journal of Endocrinology · doi:10.1530/joe-15-0409 · Cited by 121
Diabetes and bone health: latest evidence and clinical implications
Sundararaghavan, V. L., Mazur, M. M., Evans, B., Liu, J., & Ebraheim, N. A. (2017) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x16687480 · Cited by 124
Emerging neuroprotective effect of metformin in Parkinson’s disease: A molecular crosstalk
Paudel, Y. N., Angelopoulou, E., Piperi, C., Shaikh, M. F., & Othman, I. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2019.104593 · Cited by 116
Guan, Y., Wang, D., Bu, H., Zhao, T., & Wang, H. (2020) · International Journal of Endocrinology · doi:10.1155/2020/5150684 · Cited by 106
Suppression of the HSF1‐mediated proteotoxic stress response by the metabolic stress sensor AMPK
Dai, S., Tang, Z., Cao, J., Zhou, W. Y., Li, H., Sampson, S. B., & Dai, C. (2014) · The EMBO Journal · doi:10.15252/embj.201489062 · Cited by 121
Microparticulate and nanoparticulate drug delivery systems for metformin hydrochloride
Çetin, M., & Şahin, S. (2015) · Drug Delivery · doi:10.3109/10717544.2015.1089957 · Cited by 118
Wang, P., Ma, T., Guo, D., Hu, K., Shu, Y., Xu, H. H. K., & Schneider, A. (2017) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2470 · Cited by 113
Ainuddin, J. A., Karim, N., Zaheer, S., Ali, S. S., & Hasan, A. A. (2015) · Journal of Diabetes Research · doi:10.1155/2015/325851 · Cited by 108
Li, B., Chauvin, C., Paulis, D. D., Oliveira, F. D., Gharib, A., Vial, G., Lablanche, S., Leverve, X. M., Bernardi, P., Ovize, M., et al. (2012) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2012.05.011 · Cited by 124
Antidiabetic Drugs: Mechanisms of Action and Potential Outcomes on Cellular Metabolism
Meneses, M. J., Silva, B. M., Sousa, M., Sá, R., Oliveira, P. F., & Alves, M. G. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150710145753 · Cited by 132
Head, S. A., Shi, W., Zhao, L., Gorshkov, K., Pasunooti, K., Chen, Y., Deng, Z., Li, R.-J., Shim, J. S., Tan, W., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1512867112 · Cited by 111
Han, G., Gong, H., Wang, Y., Guo, S., & Liu, K. (2015) · Cancer Biology & Therapy · doi:10.4161/15384047.2014.987021 · Cited by 107
Ahmed, M. A., Muntingh, G. L., & Rheeder, P. (2016) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-016-0088-3 · Cited by 131
New therapies for advanced, recurrent, and metastatic endometrial cancers
Makker, V., Green, A. K., Wenham, R. M., Mutch, D. G., Davidson, B. A., & Miller, D. S. (2017) · Gynecologic Oncology Research and Practice · doi:10.1186/s40661-017-0056-7 · Cited by 111
Ganie, M. A., Khurana, M. L., Nisar, S., Shah, P. A., Shah, Z. A., Kulshrestha, B., Gupta, N., Zargar, M. A., Wani, T. A., Mudasir, S., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1040 · Cited by 109
Dietary plant flavonoids in prevention of obesity and diabetes
Dinda, B., Dinda, M., Roy, A., & Dinda, S. (2019) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2019.08.006 · Cited by 113
Metformin Plays a Dual Role in MIN6 Pancreatic β Cell Function through AMPK-dependent Autophagy
Jiang, Y., Huang, W., Wang, J., Xu, Z., He, J., Lin, X., Zhou, Z., & Zhang, J. (2014) · International Journal of Biological Sciences · doi:10.7150/ijbs.7929 · Cited by 108
Metformin, beyond an insulin sensitizer, targeting heart and pancreatic β cells
Yang, X., Xu, Z., Zhang, C., Cai, Z., & Zhang, J. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.09.019 · Cited by 121
Poolsup, N., Suksomboon, N., & Amin, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109985 · Cited by 107
“A decreased risk for gestational hypertension may have resulted from decreased inflammatory response and decreased insulin resistance via complex actions of metformin on maternal endothelial cell [41].”
BackgroundTargeting LKB1 signaling in cancer
Korsse, S. E., Peppelenbosch, M. P., & van Veelen, W. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.12.006 · Cited by 119
A preclinical overview of metformin for the treatment of type 2 diabetes
Zhou, T., Xu, X., Du, M., Zhao, T., & Wang, J. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.085 · Cited by 116
Sharma, P., & Kumar, S. (2018) · Cellular Oncology · doi:10.1007/s13402-018-0398-0 · Cited by 108
Structural and Functional Rescue of Chronic Metabolically Stressed Optic Nerves through Respiration
Harun-Or-Rashid, M., Pappenhagen, N., Palmer, P. G., Smith, M. A., Gevorgyan, V., Wilson, G. N., Crish, S. D., & Inman, D. M. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.3652-17.2018 · Cited by 105
Metformin and the Risk of Dementia in Type 2 Diabetes Patients
Chin-Hsiao, T. (2019) · Aging and disease · doi:10.14336/ad.2017.1202 · Cited by 98
Can ovarian aging be delayed by pharmacological strategies?
Zhang, J., Chen, Q., Du, D., Wu, T., Wen, J., Wu, M., Zhang, Y., Yan, W., Zhou, S., Li, Y., et al. (2019) · Aging · doi:10.18632/aging.101784 · Cited by 108
Fragile X Syndrome: From Molecular Aspect to Clinical Treatment
Protic, D. D., Aishworiya, R., Salcedo‐Arellano, M. J., Tang, S. J., Milisavljevic, J., Mitrovic, F., Hagerman, R. J., & Budimirovic, D. B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23041935 · Cited by 118
Kohlstedt, K., Trouvain, C., Boettger, T., Shi, L., Fißlthaler, B., & Fleming, I. (2013) · Circulation Research · doi:10.1161/circresaha.113.301282 · Cited by 112
Marycz, K., Tomaszewski, K. A., Kornicka, K., Henry, B. M., Wroński, S., Tarasiuk, J., & Marędziak, M. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/9785890 · Cited by 114
In Vitro Antidiabetic Activity and Mechanism of Action of Brachylaena elliptica (Thunb.) DC
Sagbo, I. J., van de Venter, M., Koekemoer, T., & Bradley, G. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/4170372 · Cited by 128
The Current Drug Treatment Landscape for Diabetes and Perspectives for the Future
Bailey, C. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.144 · Cited by 102
Zhang, J., Sun, C., Yan, Y., Chen, Q., Luo, F., Zhu, X., Li, X., & Chen, K. (2012) · Food Chemistry · doi:10.1016/j.foodchem.2012.06.004 · Cited by 102
Saber, M. M., Al-mahallawi, A. M., Nassar, N. N., Stork, B., & Shouman, S. A. (2018) · BMC Cancer · doi:10.1186/s12885-018-4727-5 · Cited by 102
Uppal, S., Italiya, K. S., Chitkara, D., & Mittal, A. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.09.049 · Cited by 106
The Ethnopharmacologic Contribution to Bioprospecting Natural Products
Buenz, E. J., Verpoorte, R., & Bauer, B. A. (2017) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010617-052703 · Cited by 109
Triggle, C. R., & Ding, H. (2017) · Acta Physiologica · doi:10.1111/apha.12644 · Cited by 100
Inhibition of O-GlcNAc transferase activity reprograms prostate cancer cell metabolism
Itkonen, H., Gorad, S. S., Duveau, D., Martin, S. E., Barkovskaya, A., Bathen, T., Moestue, S., & Mills, I. (2016) · OncoTarget · doi:10.18632/oncotarget.7039 · Cited by 83
Metformin and metabolic diseases: a focus on hepatic aspects
Zheng, J., Woo, S., Hu, X., Botchlett, R. E., Chen, L., Huo, Y., & Wu, C. (2015) · Frontiers of Medicine · doi:10.1007/s11684-015-0384-0 · Cited by 107
Revisiting the membrane-centric view of diabetes
Pilon, M. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0342-0 · Cited by 107
Nyane, N. A., Tlaila, T. B., Malefane, T. G., Ndwandwe, D. E., & Owira, P. M. O. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.03.042 · Cited by 101
Kokil, G. R., Veedu, R. N., Ramm, G. A., Prins, J. B., & Parekh, H. S. (2015) · Chemical Reviews · doi:10.1021/cr5002832 · Cited by 109
The Pancreatic β-Cell: A Bioenergetic Perspective
Nicholls, D. G. (2016) · Physiological Reviews · doi:10.1152/physrev.00009.2016 · Cited by 98
Liu, F., Yan, L., Wang, Z., Lu, Y., Chu, Y., Li, X., Liu, Y., Rui, D., Nie, S., & Xiang, H. (2017) · Oncotarget · doi:10.18632/oncotarget.13762 · Cited by 99
“It can reduce hyperinsulinemia, improve insulin resistance [7], and lower blood glucose concentrations in T2DM patients without causing hyperglycemia [8].”
BackgroundMetabolic Effects of Metformin in the Failing Heart
Dziubak, A., Wójcicka, G., Wojtak, A., & Bełtowski, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102869 · Cited by 104
The regulation of PKA signaling in obesity and in the maintenance of metabolic health
London, E., & Stratakis, C. A. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108113 · Cited by 102
Lin, H., Li, N., He, H., Ying, Y., Sunkara, S., Luo, L., Lv, N., Huang, D., & Luo, Z. (2015) · Molecular Pharmacology · doi:10.1124/mol.115.099549 · Cited by 102
Rapid Diagnosis and Prognosis of de novo Acute Myeloid Leukemia by Serum Metabonomic Analysis
Wang, Y., Zhang, L., Chen, W., Wang, J., Li, N., Li, J., Mi, J., Zhang, W., Li, Y., Wu, S., et al. (2013) · Journal of Proteome Research · doi:10.1021/pr400403p · Cited by 98
Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects
Salvatore, T., Pafundi, P. C., Galiero, R., Rinaldi, L., Caturano, A., Vetrano, E., Aprea, C., Albanese, G., Di Martino, A., Ricozzi, C., et al. (2020) · Biomedicines · doi:10.3390/biomedicines9010003 · Cited by 97
Galdieri, L., Gatla, H., Vancurova, I., & Vancura, A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.742247 · Cited by 94
Zha, Q.-B., Wei, H.-X., Li, C.-G., Liang, Y.-D., Xu, L.-H., Bai, W.-J., Pan, H., He, X.-H., & Ouyang, D.-Y. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00597 · Cited by 95
Cheng, G., Zielonka, J., McAllister, D. M., Tsai, S., Dwinell, M. B., & Kalyanaraman, B. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.272 · Cited by 100
AMPK Activation by Metformin Promotes Survival of Dormant ER+ Breast Cancer Cells
Hampsch, R. A., Wells, J. D., Traphagen, N. A., McCleery, C. F., Fields, J. L., Shee, K., Dillon, L. M., Pooler, D. B., Lewis, L. D., Demidenko, E., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-0269 · Cited by 98
The Role of Mitochondria in Diabetic Kidney Disease
Hallan, S. I., & Sharma, K. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0748-0 · Cited by 98
Rho-kinase/AMPK axis regulates hepatic lipogenesis during overnutrition
Hu, H., Lee, S., Sousa‐Lima, I., Kim, S. S., Hwang, W. M., Dagon, Y., Yang, W.-M., Cho, S., Kang, M., Seo, J. A., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci63562 · Cited by 93
General aspects of muscle glucose uptake
Alvim, R. D. O., CHEUHEN, M. R., MACHADO, S. R., de Sousa, A. G. P., & SANTOS, P. C. J. L. (2015) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765201520140225 · Cited by 103
Metadata
- Authors
- Viollet, B., Guigas, B., Garcia, N. S., Leclerc, J., Foretz, M., & Andreelli, F.
- Affiliations
- INSERM, U1016, Institut Cochin, Paris, France
- Leiden University Medical Center (NL)
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Leclerc, Jocelyne
- Foretz, Marc
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2011-11-11
- Volume
- 122
- Issue
- 6
- Pages
- 253-270
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- PMC
- PMC3398862
- OpenAlex
- W2154024784
- Cited by
- 1,720
- References
- 167
- Citations by year
- 2026: 63 · 2025: 85 · 2024: 96 · 2023: 103 · 2022: 106 · 2021: 143 · 2020: 155 · 2019: 135 · 2018: 141 · 2017: 156 · 2016: 137 · 2015: 144 · 2014: 117 · 2013: 104 · 2012: 34
- FWCI
- 7.43
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- HAL (submittedVersion, other-oa)
- Leiden Repository (Leiden University) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
- Keywords
- metformin, type 2 diabetes, biguanides, AMPK, mitochondrial complex I inhibition, hepatic gluconeogenesis, hepatic glucose production, polycystic ovary syndrome, hepatic steatosis, diabetes complications, adjuvant cancer therapy, gestational diabetes mellitus, prediabetes, pharmacogenetics, personalized medicine
- MeSH terms
- Animals, Cardiovascular System, Diabetic Nephropathies, Female, Humans, Hypoglycemic Agents, Metformin, Neoplasms, Polycystic Ovary Syndrome, Circadian Clocks
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.